Update on Hepatitis B Management
 |
|

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Download and review key data selected by Daniel Shouval, MD on clinical HBV data that was presented at the 2008 EASL meeting in Milan. Use the slides in your own presentations!
Format: Microsoft PowerPoint (.ppt) | File size: 804 KB | Date posted: 5/9/2008
Slide topics include:
|
Browse Slides by Date - Descending
Active Management of Oral Nucleos(t)ide Analogue Therapy for Hepatitis B
 |
|

Review on-treatment HBV guidelines including the relationships between early responses to oral anti-HBV agents and future treatment outcomes.
Format: Microsoft PowerPoint (.ppt) | File size: 1,289 KB | Date posted: 3/13/2008
Slide topics include:
|
Causes and Management of Drug-Resistant HBV Infection
 |
|

Format: Microsoft PowerPoint (.ppt) | File size: 602 KB | Date posted: 2/4/2008
|
A Case-Based Approach to Managing Resistance in Chronic HBV Infection
 |
|

Emmet B. Keeffe, MD, MACP, reviews steps to prevent, identify and manage HBV resistance to oral agents.
Format: Microsoft PowerPoint (.ppt) | File size: 2,204 KB | Date posted: 12/18/2007
Slide topics include:
|
Individualizing Therapy Based on Treatment History and On-Treatment Response
 |
|

Learn about the causes of nonresponse and strategies for individualizing treatment in patients with hepatitis C.
Format: Microsoft PowerPoint (.ppt) | File size: 3,520 KB | Date posted: 12/7/2007
Slide topics include:
|
New Management Strategies for HCV Nonresponders and Relapsers
 |
|

Format: Microsoft PowerPoint (.ppt) | File size: 1,079 KB | Date posted: 12/5/2007
|
Clinical Updates in HBV Treatment
 |
|

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Review the most clinically relevant HBV data from the 2007 Boston meeting and download the slides for use in your own presentations.
Format: Microsoft PowerPoint (.ppt) | File size: 650 KB | Date posted: 11/28/2007
Slide topics include:
|
Update on Investigational Agents in HCV: 2007
 |
|

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Review the most clinically relevant data on HCV investigational agents from the 2007 Boston meeting and download the slides for use in your own presentations.
Format: Microsoft PowerPoint (.ppt) | File size: 427 KB | Date posted: 11/21/2007
Slide topics include:
|
Debate: What Is the Optimal Management Strategy for Lamivudine Resistance in HBeAg-Negative Patients?
 |
|

Robert G. Gish, MD, and Robert P. Perrillo, MD, evaluate the best strategies for managing lamivudine resistance in patients with hepatitis B.
Format: Microsoft PowerPoint (.ppt) | File size: 680 KB | Date posted: 11/4/2007
|
Debate: What Is the Best Rescue Strategy for the Management of Primary Nonresponse: Switch or Add?
 |
|

Robert G. Gish, MD, and Nezam H. Afdhal, MD, FRCPI, debate the optimal strategy for management of hepatitis B patients with primary nonresponse.
Format: Microsoft PowerPoint (.ppt) | File size: 588 KB | Date posted: 11/4/2007
|
Debate: Nucleos(t)ide Analogues vs Peginterferon in Treatment-Naive HBeAg-Positive Patients
 |
|

Robert P. Perrillo, MD, and Jules L. Dienstag, MD, debate the use of peginterferon vs nucleos(t)ide analogues as first-line therapy for HBeAg-positive hepatitis B patients.
Format: Microsoft PowerPoint (.ppt) | File size: 627 KB | Date posted: 11/4/2007
|
|

Use the following filters to quickly browse and download slides for your talks
Browse slides by:
All Slides by Date (173)
Program Type
Topic
Featured Content
Review a module and Interactive Case Challenge and use the new HBV DNA monitoring tool.
2008 Independent Conference Report on Hepatitis B and C Virus Resistance to Antiviral Therapies.
Review new data and Expert Highlights from the 2008 hepatitis meeting.
|
|